Chemotherapy Exposure and outcomes Among Patients Diagnosed with Chronic Lymphoid Leukemia
JG Kuiper(Pharmo Institute), Maren Gaudig(Janssen (Germany)), P. Musingarimi(Janssen (United Kingdom)), Christoph Tapprich(Johnson & Johnson (Germany)), FJ Penning-van Beest(Pharmo Institute)
Cited by 0
Related Papers
Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings
|Bone Marrow Transplantation|2005|81
Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes
|Experimental Hematology|2008|58
Burden of illness of follicular lymphoma and marginal zone lymphoma
|Annals of Hematology|2018|32
Phase <scp>II</scp> study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: <scp>DSMM XI</scp> trial
|British Journal of Haematology|2017|30
Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma
|Bone Marrow Transplantation|2003|26